CRMD Q1 2018 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$518M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$23,210-41.3% YoY

Gross Profit

-$5,365-23.1% margin

Operating Income

-$10M-43898.4% margin

Net Income

-$10M-43882.5% margin

EPS (Diluted)

$-0.68

QoQ Revenue Growth

-74.9%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$373,293

Balance Sheet

Total Assets

$10M

Total Liabilities

$9M

Stockholders' Equity

$840,692

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23,210	$39,559	-41.3%
Gross Profit	-$5,365	-$54,012	+90.1%
Operating Income	-$10M	-$8M	-33.7%
Net Income	-$10M	-$8M	-34.1%